ANDA 200998, held by Taro. Meprobamate.
As of Nov 14, 2026, ANDA 200998 (Meprobamate), held by Taro, was first approved by FDA on May 23, 2011, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 23, 2011 | Original application | Approved | None posted |
| Meprobamate200MG · tablet;oral | Meprobamate | Discontinued |
| Meprobamate400MG · tablet;oral | Meprobamate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
